Kim SI - Search Results

1

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

Creutzberg CL, Kim JW, Eminowicz G, Allanson E, Eberst L, Kim SI, Nout RA, Park JY, Lorusso D, Mileshkin L, Ottevanger PB, Brand A, Mezzanzanica D, Oza A, Gebski V, Pothuri B, Batley T, Gordon C, Mitra T, White H, Howitt B, Matias-Guiu X, Ray-Coquard I, Gaffney D, Small W Jr, Miller A, Concin N, Powell MA, Stuart G, Bookman MA; participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research. Creutzberg CL, et al. Among authors: kim si, kim jw. Lancet Oncol. 2024 Sep;25(9):e420-e431. doi: 10.1016/S1470-2045(24)00192-X. Lancet Oncol. 2024. PMID: 39214113

2

Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.

Kim SI, Lee JW, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS, Seo JS. Kim SI, et al. Among authors: kim hs, kim jw. Gynecol Oncol. 2018 Feb;148(2):375-382. doi: 10.1016/j.ygyno.2017.12.005. Epub 2017 Dec 9. Gynecol Oncol. 2018. PMID: 29233531

3

Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.

Kim SI, Cho JH, Seol A, Kim YI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS. Kim SI, et al. Among authors: kim yi, kim hs, kim jw. Gynecol Oncol. 2019 Apr;153(1):3-12. doi: 10.1016/j.ygyno.2019.01.008. Epub 2019 Jan 12. Gynecol Oncol. 2019. PMID: 30642625

4

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.

Kim SI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS. Kim SI, et al. Among authors: kim hs, kim jw. J Ovarian Res. 2019 May 7;12(1):40. doi: 10.1186/s13048-019-0511-7. J Ovarian Res. 2019. PMID: 31064392 Free PMC article.

5

Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.

Kim SI, Lee M, Lee S, Suh DH, Kim HS, Kim K, Chung HH, No JH, Kim JW, Park NH, Song YS, Kim YB. Kim SI, et al. Among authors: kim yb, kim hs, kim jw, kim k. Gynecol Oncol. 2019 Oct;155(1):75-82. doi: 10.1016/j.ygyno.2019.07.019. Epub 2019 Aug 2. Gynecol Oncol. 2019. PMID: 31383569

6

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study.

Paik ES, Lee YJ, Lee JY, Shin W, Park SY, Kim SI, Kim JW, Choi CH, Kim BG. Paik ES, et al. Among authors: kim bg, kim si, kim jw. J Clin Med. 2019 Nov 8;8(11):1920. doi: 10.3390/jcm8111920. J Clin Med. 2019. PMID: 31717415 Free PMC article.

7

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.

Kim SI, Lee M, Kim HS, Chung HH, Kim JW, Park NH, Song YS. Kim SI, et al. Among authors: kim hs, kim jw. Cancer Res Treat. 2020 Oct;52(4):1229-1241. doi: 10.4143/crt.2020.557. Epub 2020 Jul 27. Cancer Res Treat. 2020. PMID: 32718143 Free PMC article.

8

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy.

Tjokrowidjaja A, Lee CK, Friedlander M, Gebski V, Gladieff L, Ledermann J, Penson R, Oza A, Korach J, Huzarski T, Manso L, Pisano C, Asher R, Lord SJ, Kim SI, Lee JY, Colombo N, Park-Simon TW, Fujiwara K, Sonke G, Vergote I, Kim JW, Pujade-Lauraine E. Tjokrowidjaja A, et al. Among authors: kim si, kim jw. Eur J Cancer. 2020 Nov;139:59-67. doi: 10.1016/j.ejca.2020.08.021. Epub 2020 Sep 23. Eur J Cancer. 2020. PMID: 32977221 Clinical Trial.

9

Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer.

Kim SI, Lee EJ, Lee M, Chung H, Kim JW, Park NH, Song YS, Kim HS. Kim SI, et al. Among authors: kim hs, kim jw. Int J Gynecol Cancer. 2020 Dec;30(12):1943-1950. doi: 10.1136/ijgc-2020-001517. Epub 2020 Oct 14. Int J Gynecol Cancer. 2020. PMID: 33055266

10

Impact of Adjuvant Radiotherapy on Survival Outcomes in Intermediate-Risk, Early-Stage Cervical Cancer: Analyses Regarding Surgical Approach of Radical Hysterectomy.

Kim SI, Kim TH, Lee M, Kim HS, Chung HH, Lee TS, Jeon HW, Kim JW, Park NH, Song YS. Kim SI, et al. Among authors: kim th, kim hs, kim jw. J Clin Med. 2020 Nov 3;9(11):3545. doi: 10.3390/jcm9113545. J Clin Med. 2020. PMID: 33153125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,488 results

Search Page

Filters